• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Medical Device Recalls

  • Print
  • Share
  • E-mail
-
1 to 10 of 12 Results
510(K) Number: K171768
 
 1 
 2 
 > 
Results per Page
New Searchexport reports to excelExport to Excel | HelpHelp
Product Description
Sort by Product Name [A-Z]
Sort by Product Name [Z-A]
Recall
Class
Sort by Recall Class [0-9]
Sort by Recall Class [9-0]
FDA Recall
Posting Date
Sort by Date Classified [0-9]
Sort by Date Classified [9-0]
Recalling Firm
Sort by Recalling Firm [A-Z]
Sort by Recalling Firm [Z-A]
TRIDENTII HEMI CLUSTER44B- Indicated for use in primary and revision patients at high risk of hip d... 2 04/25/2024 Howmedica Osteonics Corp.
TRIDENTII HEMI CLUSTER48D-indicated for use in primary and revision patients at high risk of hip dis... 2 04/25/2024 Howmedica Osteonics Corp.
TRIDENTII HEMI CLUSTER50D- Indicated for use in primary and revision patients at high risk of hip di... 2 04/25/2024 Howmedica Osteonics Corp.
TRIDENTII HEMI CLUSTER52E-Indicated for use in primary and revision patients at high risk of hip dis... 2 04/25/2024 Howmedica Osteonics Corp.
TRIDENTII HEMI CLUSTER54E- Indicated for use in primary and revision patients at high risk of hip d... 2 04/25/2024 Howmedica Osteonics Corp.
TRIDENTII PSL CLUSTER64H- Indicated for use in primary and revision patients at high risk of hip dis... 2 04/25/2024 Howmedica Osteonics Corp.
TRIDENTII HEMI CLUSTER66H- Indicated for use in primary and revision patients at high risk of hip d... 2 04/25/2024 Howmedica Osteonics Corp.
TRIDENTII PSL CLUSTER48D- Indicated for use in primary and revision patients at high risk of hip di... 2 04/25/2024 Howmedica Osteonics Corp.
TRIDENTII PSL CLUSTER50D- Indicated for use in primary and revision patients at high risk of hip dis... 2 04/25/2024 Howmedica Osteonics Corp.
TRIDENTII PSL CLUSTER52E- Indicated for use in primary and revision patients at high risk of hip dis... 2 04/25/2024 Howmedica Osteonics Corp.
-
-